[Case of cerebral arteriosclerosis with nuclear ophthalmoplegia].
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Calcium pangamate (CP) in patients with the cerebrasthenic syndrome of atherosclerotic genesis facilitates a decrease in the cholesterol index of atherogenicity due to increased levels of serum high-density lipoproteins (HDLP). One of the factors contributing to an increase in HDLP levels in the patients' blood serum under the impact of CP is the stimulation of the phospholipid incorporation into HDLP.
Explore the source record for details and available documents.
Explore the source record for details and available documents.